Heparan sulfate disaccharide concentrations (ng/ml) in CSF of 11 subjects
| 01-01 | 01-02 | 01-03 | 01-04 | 01-05 | 01-06 | 01-07 | 01-08 | 02-01 | 02-02 | 02-03 | Mean | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D0H0 | 0.07 | 0.00 | 0.00 | 0.00 | 0.03 | 0.58 | 0.00 | 0.02 | 0.37 | 0.06 | 0.00 | 0.10 |
| D0A0 | 20.05 | 3.16 | 36.08 | 1.60 | 20.82 | 33.99 | 8.62 | 17.98 | 33.36 | 16.62 | 11.20 | 18.50 |
| D0H6 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| D2H0 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| D0S0 | 5.12 | 2.00 | 8.82 | 0.22 | 5.55 | 8.07 | 2.38 | 4.33 | 7.97 | 4.04 | 2.89 | 4.67 |
| D0A6 | 4.28 | 1.40 | 5.71 | 0.17 | 2.91 | 4.26 | 1.19 | 2.16 | 2.90 | 2.48 | 1.83 | 2.66 |
| D2A0 | 0.24 | 0.02 | 0.27 | 0.00 | 0.41 | 0.53 | 0.18 | 0.22 | 0.35 | 0.51 | 0.27 | 0.27 |
| D2H6 | 0.00 | 0.00 | 0.00 | 0.00 | 0.33 | 0.48 | 0.06 | 0.04 | 0.31 | 0.40 | 0.23 | 0.17 |
| D0S6 | 1.03 | 0.08 | 0.96 | 0.00 | 2.36 | 2.79 | 0.72 | 1.04 | 1.62 | 2.37 | 1.33 | 1.30 |
| D2S0 | 3.62 | 1.32 | 4.58 | 0.10 | 10.61 | 5.33 | 1.50 | 1.80 | 3.62 | 3.86 | 2.58 | 3.54 |
| D2A6 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 | 0.01 | 0.00 | 0.02 | 0.00 | 0.00 |
| D2S6 | 1.99 | 0.54 | 2.66 | 0.00 | 2.50 | 2.45 | 0.66 | 1.78 | 1.57 | 2.34 | 1.36 | 1.62 |
Heparan sulfate disaccharide concentrations in CSF of 11 subjects [8 subjects from Site 1 (01-xx) and 3 subjects from Site 2 (02-xx)]. Three subject samples are not individually available for inclusion in this table but are incorporated into Figure 3.